Genome Editing Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Genome Editing Market 

5.1. COVID-19 Landscape: Genome Editing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Genome Editing Market, By Technology

8.1. Genome Editing Market, by Technology, 2024-2033

8.1.1. (CRISPR)/Cas9

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. ZFN

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Meganuclease

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. TALENs/MegaTALs

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Genome Editing Market, By Delivery Method

9.1. Genome Editing Market, by Delivery Method, 2024-2033

9.1.1. Ex-vivo

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. In-vivo

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Genome Editing Market, By Application 

10.1. Genome Editing Market, by Application, 2024-2033

10.1.1. Genetic Engineering

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Clinical Applications

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Genome Editing Market, By Mode

11.1. Genome Editing Market, by Mode, 2024-2033

11.1.1. Contract

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. In-house

11.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Genome Editing Market, By End-use

12.1. Genome Editing Market, by End-use, 2024-2033

12.1.1. Biotechnology and Pharmaceutical Companies

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. Contract Research Organizations

12.1.2.1. Market Revenue and Forecast (2021-2033)

12.1.3. Academic and Government Research Institutes

12.1.3.1. Market Revenue and Forecast (2021-2033)

12.1.4. OSAT

12.1.4.1. Market Revenue and Forecast (2021-2033)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 13. Global Genome Editing Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Technology (2021-2033)

13.1.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.1.3. Market Revenue and Forecast, by Application (2021-2033)

13.1.4. Market Revenue and Forecast, by Mode (2021-2033)

13.1.5. Market Revenue and Forecast, by End-use (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Technology (2021-2033)

13.1.6.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.1.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.1.6.4. Market Revenue and Forecast, by Mode (2021-2033)

13.1.6.5. Market Revenue and Forecast, by End-use (2021-2033) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Technology (2021-2033)

13.1.7.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.1.7.3. Market Revenue and Forecast, by Application (2021-2033)

13.1.7.4. Market Revenue and Forecast, by Mode (2021-2033)

13.1.7.5. Market Revenue and Forecast, by End-use (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Technology (2021-2033)

13.2.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.2.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.4. Market Revenue and Forecast, by Mode (2021-2033) 

13.2.5. Market Revenue and Forecast, by End-use (2021-2033) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Technology (2021-2033)

13.2.6.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.2.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.7. Market Revenue and Forecast, by Mode (2021-2033) 

13.2.8. Market Revenue and Forecast, by End-use (2021-2033) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Technology (2021-2033)

13.2.9.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.2.9.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.10. Market Revenue and Forecast, by Mode (2021-2033)

13.2.11. Market Revenue and Forecast, by End-use (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Technology (2021-2033)

13.2.12.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.2.12.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.12.4. Market Revenue and Forecast, by Mode (2021-2033)

13.2.13. Market Revenue and Forecast, by End-use (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Technology (2021-2033)

13.2.14.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.2.14.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.14.4. Market Revenue and Forecast, by Mode (2021-2033)

13.2.15. Market Revenue and Forecast, by End-use (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Technology (2021-2033)

13.3.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.3.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.4. Market Revenue and Forecast, by Mode (2021-2033)

13.3.5. Market Revenue and Forecast, by End-use (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Technology (2021-2033)

13.3.6.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.3.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.6.4. Market Revenue and Forecast, by Mode (2021-2033)

13.3.7. Market Revenue and Forecast, by End-use (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Technology (2021-2033)

13.3.8.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.3.8.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.8.4. Market Revenue and Forecast, by Mode (2021-2033)

13.3.9. Market Revenue and Forecast, by End-use (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Technology (2021-2033)

13.3.10.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.3.10.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.10.4. Market Revenue and Forecast, by Mode (2021-2033)

13.3.10.5. Market Revenue and Forecast, by End-use (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Technology (2021-2033)

13.3.11.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.3.11.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.11.4. Market Revenue and Forecast, by Mode (2021-2033)

13.3.11.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Technology (2021-2033)

13.4.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.4.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.4. Market Revenue and Forecast, by Mode (2021-2033)

13.4.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Technology (2021-2033)

13.4.6.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.4.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.6.4. Market Revenue and Forecast, by Mode (2021-2033)

13.4.7. Market Revenue and Forecast, by End-use (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Technology (2021-2033)

13.4.8.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.4.8.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.8.4. Market Revenue and Forecast, by Mode (2021-2033)

13.4.9. Market Revenue and Forecast, by End-use (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Technology (2021-2033)

13.4.10.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.4.10.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.10.4. Market Revenue and Forecast, by Mode (2021-2033)

13.4.10.5. Market Revenue and Forecast, by End-use (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Technology (2021-2033)

13.4.11.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.4.11.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.11.4. Market Revenue and Forecast, by Mode (2021-2033)

13.4.11.5. Market Revenue and Forecast, by End-use (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Technology (2021-2033)

13.5.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.5.3. Market Revenue and Forecast, by Application (2021-2033)

13.5.4. Market Revenue and Forecast, by Mode (2021-2033)

13.5.5. Market Revenue and Forecast, by End-use (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Technology (2021-2033)

13.5.6.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.5.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.5.6.4. Market Revenue and Forecast, by Mode (2021-2033)

13.5.7. Market Revenue and Forecast, by End-use (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Technology (2021-2033)

13.5.8.2. Market Revenue and Forecast, by Delivery Method (2021-2033)

13.5.8.3. Market Revenue and Forecast, by Application (2021-2033)

13.5.8.4. Market Revenue and Forecast, by Mode (2021-2033)

13.5.8.5. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 14. Company Profiles

14.1. Merck KGaA.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Cibus Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Recombinetics

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Sangamo Therapeutics

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Cellectis S.A.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. AstraZeneca

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Takara Bio Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Horizon Discovery Ltd. (Revvity, Inc.)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Editas Medicine

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Precision BioSciences

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms